Current Opportunities

BioDiagnostics is seeking global distributors for its CDC recommended HSV-2 BioCard™

The BioCard™ HSV-2 testing technology was initially manufactured by BioDiagnostics as a low-cost screening method to detect undiagnosed infections of Genital Herpes Simplex Virus Type 2 (HSV-2). It later became recommended by the CDC for confirmation of (HSV-2) referred to in the “Sexually Transmitted Infections Treatment Guidelines, 2021” (referred to in its BioKit™ private label).

The development of the BioCard™ technology brought together the speed of rapid tests with an accuracy on a par or better than ELISA or CLIA systems. This enabled unrestricted sample throughput without analysers and their high associated costs, providing access to smaller clinics as well as large laboratory groups all utilising the BioCard™ technology.

Visit Herpes Simplex Virus Rapid Test – HSV2 BioCard™ Rapid Test from BioDiagnostics for more details, and to explore becoming distributor for this essential test in your territory.

HSV-2 BioCard

I found Bio-diagnostics more than helpful, replacing all our allergens in a very quick and efficient way, reducing the complexity of ordering and providing an excellent service to us.

Melanie Paddon, OPD, Circle, Bath.

The company and individual staff are very attentive and efficient at responding to our needs. I would not hesitate in recommending Bio-diagnostics to provide a solution for any potential customers. Thanks Bio-diagnostics.

Martin Davies, Manager Immunology, Prince Philip Hospital, Hywel Dda University Health Board

Brilliant support from very knowledgeable and friendly team. Nothing is ever too much trouble - Thank you!

Pearl Huey, BCULHB Service Manager for Cellular Pathology.

We have been customers of Bio-Diagnostics for over 10 years and have always found their products to be of a high and consistent quality, and customer service to be excellent.